DGAP-News: David Edwards joins Nanostart-holding BioMers as its new CEO
(firmenpresse) - DGAP-News: Nanostart AG / Key word(s): Miscellaneous
David Edwards joins Nanostart-holding BioMers as its new CEO
11.05.2011 / 06:00
---------------------------------------------------------------------
- Top executive brings over 20 years of experience in consumer med-tech
products
- Most recently responsible for annual sales of USD 500 million
- 'SimpliClear is a breakthrough innovation delivering aesthetic benefit
and superior clinical outcomes to orthodontic appliances'
Frankfurt / Singapore - May 11, 2011 - David Edwards is the new Chief
Executive Officer of the Singaporean Nanostart holding
BioMers Pte Ltd. The top executive will be leveraging his extensive
experience in building brands to drive BioMers' commercial expansion and
launch of flagship product, SimpliClear(TM). The SimpliClear product range
is the world's only completely translucent orthodontic system. Mr. Edwards
is based in BioMers' Singapore headquarters and is responsible for the
company's worldwide business, reporting to the Board of Directors.
Mr. Edwards brings broad management experience and global brand development
expertise in the consumer and med-tech space to the company, and has an
impressive track record in growing businesses in the US, Europe and Asia.
Most recently, Mr. Edwards was responsible for annual sales of over USD 500
million as the President of Asia-Pacific at Bausch&Lomb, one of the
leading producers of eye health products, responsible for the Asian eye
health portfolio. Under his leadership, Bausch&Lomb's business in Asia
was turned around and new products were successfully launched. Bausch&Lomb has more than 10,000 employees across 35 countries. Its total revenues
amount to more than USD 2 bn.
Mr. Edwards also spent more than ten years with Johnson&Johnson in
several top management positions. This includes leading roles as business
unit head at Johnson&Johnson's diabetes business (encompassing Western
Europe, Eastern Europe, Middle East and Africa), the vision care business
(Asia Pacific, including China and India) and the consumer nutritionals
business (Europe). He achieved strong growth in his relevant areas, with
the successful launch of numerous products and product innovations. Johnson&Johnson has around 140,000 employees worldwide across 57 countries. In
2010 the company achieved revenues of about USD 62 bn.
Further positions include local, regional and global roles at Nestléin the
US, in Europe and at the global headquarters in Vevey, Switzerland.
David Edwards comments on his new position: 'I am looking forward to my new
role at BioMers. SimpliClear is a proven product, which has been long
awaited by orthodontists and patients. It represents a breakthrough
innovation in the growing market for aesthetic orthodontic appliances and
delivers superior clinical outcomes.'
Andreas Kröll, managing director of Nanostart Asia, comments: 'We are
excited that David Edwards has joined us as CEO of BioMers. His impressive
experience and highly efficient management style combine with the
SimpliClear product to create ideal conditions for blockbuster business
success - and ensure a solid foundation for BioMers success.'
David Edwards succeeds Dr. Mervyn Fathianathan as CEO. Dr. Fathianathan is
one of the founders and a director of BioMers. He will continue as the CTO
of BioMers, and shall be responsible for customerand product development.
He added: 'With David Edwards, we have brought a top executive into BioMers
who will contribute to make the company a global leader in orthodontics.
His commitment highlights the value of our products and company. This marks
the start of rapid expansion of the company's business on a global scale.'
Nanostart holds its position in BioMers through the Nanostart Singapore
Early Stage Venture Fund. The fund's shareholding in BioMers is about 25
percent.
About Nanostart:
Nanostart AG, headquartered in the German financial capital
of Frankfurt, is the world's leading nanotechnology investment company,
with portfolio companies spanning the globe from Silicon Valley to
Singapore. The company provides venture capital financing for
nanotechnology companies in various growth phases with a focus on
innovation-driven industries of the future such as cleantech, life sciences
and IT/electronics. Through its subsidiary and venture capital fund in
Singapore, Nanostart is proud to be the investment partner of the
Singaporean government. For further information, please visit
www.nanostart.de.
About BioMers:
BioMers is a medical device company that has developed novel polymer
composite products for numerous biomedical applications. The company's
flagship product is the SimpliClear(TM) braces system, which is the world's
first and only aesthetic solution for all types of orthodontic treatments.
This translucent, almost invisible braces system is customized to each
patient, providing faster and better results. Established in 2005, BioMers
is a spin-off company from the National University of Singapore, where the
technology was invented. BioMers has received seed funding from NUS
Enterprise, venture capital funding from the Nanostart Singapore Early
Stage Venture Fund, and grants from government agencies, including SPRING
Singapore and the Economic Development Board. For more information, visit
www.biomersbraces.com
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of
offers to purchase or subscribe to securities. There will be no public
offering of securities of Nanostart AG in conjunction with the existing
listing of its shares in the 'Entry Standard' segment of the regulated
unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This
notice does not constitute a securities prospectus. Neither this notice nor
the information contained within is intended for direct or indirect
distribution within Canada, Australia or Japan.
Media contact:
Nanostart AG
Head of Corporate Communications
Dr. Hans Joachim Dürr
Goethestrasse 26-28
D-60313 Frankfurt
Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 122
e-mail: presse(at)nanostart.de
End of Corporate News
---------------------------------------------------------------------
11.05.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
123907 11.05.2011
Datum: 11.05.2011 - 06:00 Uhr
Sprache: Deutsch
News-ID 34015
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 254 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: David Edwards joins Nanostart-holding BioMers as its new CEO"
steht unter der journalistisch-redaktionellen Verantwortung von
Nanostart AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
